Market Indices


Latest News

Jefferies analyst issues BUY recommendation for ATAI on March 6,...

March 6, 2026   ATAI -3.81%

Following are the Top 5 companies based on their one-day percentage...

March 6, 2026   SCOR 0.28%

Following are the Top 5 companies based on their one-day percentage...

March 6, 2026   ESCA 3.73%

Brian Holland from D.A. Davidson issued a price target of $24.00...

March 6, 2026   MAMA 5.68%

David Grossman from Stifel Nicolaus issued a price target of $17.00...

March 6, 2026   OPRX -10.56%


Price Targets

Brian Holland from D.A. Davidson issued a price target of $24.00 for MAMA on 2026-03-06 13:50:00.The adjusted price target was set to $24.00.At the time of the announcement,

March 6, 2026   MAMA 5.68%

David Grossman from Stifel Nicolaus issued a price target of $17.00 for OPRX on 2026-03-06 11:51:00.The adjusted price target was set to $17.00.At the time of the announcement,

March 6, 2026   OPRX -10.56%

Maury Raycroft from Jefferies issued a price target of $9.00 for CMPX on 2026-03-05 21:33:00.The adjusted price target was set to $9.00.At the time of the announcement, CMPX...

March 5, 2026   CMPX -0.81%

Clara Dong from Jefferies issued a price target of $19.00 for VSTM on 2026-03-05 15:06:00.The adjusted price target was set to $19.00.At the time of the announcement, VSTM...

March 5, 2026   VSTM 2.95%

John McPeake from Rosenblatt Securities issued a price target of $40.00 for RGTI on 2026-03-05 14:23:00.The adjusted price target was set to $40.00.At the time of the announcement,

March 5, 2026   RGTI 0.71%



Market Movers

Top Gainers (%)
XOSWW
Xos Equity Warrants
0.00
22.86%
SLDB
Solid Biosciences Inc.
6.71
19.52%
BDSX
Biodesix, Inc.
18.78
18.38%
PRE
Prenetics Global Limited
17.83
18.31%
STTK
Shattuck Labs, Inc.
5.99
17.45%
FLL
Full House Resorts, Inc.
2.66
16.96%
MAPSW
WM Technology Inc
0.01
16.39%
CDIOW
Cardio Diagnostics Holdin
0.03
15.20%

Annual/Quarterly Reports Summary

In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...

November 6, 2024   AIP -6.78%

In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...

November 6, 2024   EOSEW -34.96%

In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...

November 6, 2024   EOSE -8.63%

In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...

November 5, 2024   STOK 0.87%

In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...

November 5, 2024   BSVN 1.77%